Wells Fargo posted a net income of $4.91 billion in Q2 2024, a 1% Y/Y decline. GAAP EPS of $1.33 surpassed the consensus of $1.29. Revenue grew 1% to $20.69 billion, exceeding the expected $20.29 billion. Noninterest income rose 19% to $8.77 billion.

Immutep announces results from Cohort B of the TACTI-003 Phase 2b trial. The combination of eftilagimod alfa and Merck's Keytruda shows a 35.5% ORR and 58.1% DCR in PD-L1 negative head and neck cancer patients, with no new safety concerns.

AT&T and Snowflake stocks are down after AT&T disclosed a data breach affecting nearly all customers. Cybercriminals stole phone records and metadata from a third-party cloud platform.

Leading cryptocurrencies gave up their early morning gains as the cooler-than-expected inflation data ended up becoming a ‘buy the rumor, sell the news’ event.